TEG Platelet Mapping    body {font-family: 'Open Sans', sans-serif;}

### TEG Platelet Mapping Interpretation

**% aggregation =   MAADP or AA - MAfibrin x100  
                               MAThrombin - MAfibrin**

**% Inhibition =    100 - MAADP** or **AA** **\- MAfibrin x100  
                                       MAThrombin** **\- MAfibrin**

**  
  
TEG Platelet Mapping normal values (no antiplatelet therapy)**

table.tableizer-table { font-size: 12px; border: 1px solid #CCC; font-family: Arial, Helvetica, sans-serif; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #CCC; } .tableizer-table th { background-color: #104E8B; color: #FFF; font-weight: bold; }

| Assay | Normal Values (mm) |
| --- | --- |
| MAthrombin | 60.9 (± 4.5) |
| MAfibrin | 7.5 (± 2.7) |
| MAAA | 64.6 (± 2.7) |
| MAADP | 51.1 (± 8.1) |

(Bochsen et al. 2007)

**Interpretation** (very little data available)  
  
**Aspirin resistance**  
**AA assay** showing > 50% aggregation or < 50% inhibition of platelet mapping  
**  
P2Y12 inhibitory drug resistance  
**ADP assay showing > 50% aggregation or < 50% inhibition of platelet mapping  
  
**Associated increased ischemic risk: MA ADP** \> 47mm  
  
**Associated with increased bleeding risk: MA ADP** < 31mm  

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.  
Tantry US, Biden KP, Garbel, PA  
J Am Coll Cardiol. 2005 Nov 1;46(9):1705-9. Epub 2005 Oct 10.  
https://www.ncbi.nlm.nih.gov/pubmed/16256872  
  
Perioperative Hemostasis –Coagulation for Anesthesiologist  
C. Marcucci and P. Schoettker; 2015. Pp 58-60